A Longitudinal Study on the Safety and Efficacy for Subjects With ASD Who Received MeRT



Status:Enrolling by invitation
Conditions:Neurology, Psychiatric
Therapuetic Areas:Neurology, Psychiatry / Psychology
Healthy:No
Age Range:6 - 15
Updated:4/22/2016
Start Date:April 2016
End Date:December 2017

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

A Longitudinal Study on the Safety and Efficacy for Subjects With Autism Spectrum Disorder (ASD) Who Received Magnetic EEG/ECG-Guided Resonance Therapy (MeRT)

The purpose of this study is to continue to evaluate the long-term effectiveness of Magnetic
EEG/ECG-Guided Resonance Therapy (MeRT) in children with Autism Spectrum Disorder (ASD). No
active MeRT treatment will be performed in this study.

This clinical trial is a longitudinal study designed to evaluate the safety and efficacy for
subjects with Autism Spectrum Disorder (ASD) who received Magnetic EEG/ECG-Guided Resonance
Therapy (MeRT) in the IRB approved clinical trial. A total of twenty-eight (28) subjects
will be followed in this study. After providing informed consent, twenty-eight (28) subjects
who participated in the previous protocol will be observed for up to three (3) years
post-MeRT treatment. During this period, subjects will be evaluated at 104 and 156 weeks
post-MeRT treatment.

Inclusion Criteria:

1. Subject must have completed the MeRT-001 (formerly known as MRT-001) clinical trial
conducted by the Brain Treatment Center (BTC)

2. Age between 6 and 15 years (at day of informed consent)

3. Willing and able to adhere to the study visits

Exclusion Criteria:

1. Subjects who did not participate in the MeRT-001 clinical trial.

2. Any condition which in the judgment of the investigator would prevent the subject
from completion of the study.
We found this trial at
1
site
Brain Treatment Center
Newport Beach, California 92660
?
mi
from
Newport Beach, CA
Click here to add this to my saved trials